NovoCure Ltd. (NVCR) PT Raised to $24 at H.C. Wainwright
Tweet Send to a Friend
H.C. Wainwright analyst Emily Bodnar raised the price target on NovoCure Ltd. (NASDAQ: NVCR) to $24.00 (from $22.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE